Literature DB >> 17910710

Staging of necrotizing fasciitis based on the evolving cutaneous features.

Yi-Shi Wang1, Chin-Ho Wong, Yong-Kwang Tay.   

Abstract

BACKGROUND: Necrotizing fasciitis is a severe soft-tissue infection characterized by a fulminant course and high mortality. Early recognition is difficult as the disease is often clinically indistinguishable from cellulitis and other soft-tissue infections early in its evolution. Our aim was to study the manifestations of the cutaneous signs of necrotizing fasciitis as the disease evolves.
METHODS: This was a retrospective study on patients with necrotizing fasciitis at a single institution. Their charts were reviewed to document the daily cutaneous changes from the time of presentation (day 0) through to day 4 from presentation.
RESULTS: Twenty-two patients were identified. At initial assessment (day 0), almost all patients presented with erythema, tenderness, warm skin, and swelling. Blistering occurred in 41% of patients at presentation whereas late signs such as skin crepitus, necrosis, and anesthesia were infrequently seen (0-5%). As time elapsed, more patients had blistering (77% had blisters at day 4) and eventually the late signs of necrotizing fasciitis characterized by skin crepitus, necrosis, and anesthesia (9-36%) were seen. A clinical staging system was developed based on our observations. Stage migration from early to late stage necrotizing fasciitis was evident with majority of patients in stage 1 at day 0 (59%), whereas by day 4, majority had developed into stage 3 (68%).
CONCLUSION: This study has demonstrated the continuum of cutaneous manifestations as necrotizing fasciitis evolves. This will help in the early recognition and intervention of this devastating condition.

Entities:  

Mesh:

Year:  2007        PMID: 17910710     DOI: 10.1111/j.1365-4632.2007.03201.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  27 in total

1.  Immune cell subsets in necrotizing fasciitis: an immunohistochemical analysis.

Authors:  A J Saenz; A F Koreishi; A E Rosenberg; R L Kradin
Journal:  Virchows Arch       Date:  2009-06-16       Impact factor: 4.064

2.  Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report.

Authors:  Keri Brown; Jeanine Martin; Susan Zito
Journal:  J Med Case Rep       Date:  2010-07-01

3.  Predictors of mortality for necrotizing soft-tissue infections: a retrospective analysis of 64 cases.

Authors:  Andreas Krieg; Levent Dizdar; Pablo Emilio Verde; Wolfram Trudo Knoefel
Journal:  Langenbecks Arch Surg       Date:  2014-01-11       Impact factor: 3.445

4.  Necrotizing fasciitis: treatment concepts and clinical results.

Authors:  M Leiblein; I Marzi; A L Sander; J H Barker; F Ebert; J Frank
Journal:  Eur J Trauma Emerg Surg       Date:  2017-05-08       Impact factor: 3.693

5.  [Necrotizing fasciitis. 2011 update].

Authors:  M Herr; B Grabein; H-G Palm; K Efinger; H-J Riesner; B Friemert; C Willy
Journal:  Unfallchirurg       Date:  2011-03       Impact factor: 1.000

6.  Essentials in the management of necrotizing soft-tissue infections.

Authors:  Norma Jung; Christian Eckmann
Journal:  Infection       Date:  2019-05-10       Impact factor: 3.553

7.  A Case of Subacute Necrotizing Fasciitis due to Serratia marcescens.

Authors:  Michael Roberts; David Crasto; David Roy
Journal:  J Clin Aesthet Dermatol       Date:  2021-01-01

Review 8.  Necrotizing fasciitis.

Authors:  Rukshini Puvanendran; Jason Chan Meng Huey; Shanker Pasupathy
Journal:  Can Fam Physician       Date:  2009-10       Impact factor: 3.275

9.  Severe monobacterial necrotizing soft tissue infection by group A Streptococcus: A surgical emergency.

Authors:  S Lanitis; M A A Khan; G Sgourakis; C Kontovounisios; T Papaconstandinou; C Karaliotas
Journal:  Asian Pac J Trop Biomed       Date:  2012-03

10.  Frozen sections are unreliable for the diagnosis of necrotizing soft tissue infections.

Authors:  Isaac H Solomon; Rene Borscheid; Alvaro C Laga; Reza Askari; Scott R Granter
Journal:  Mod Pathol       Date:  2017-12-15       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.